Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (191-200 of 238) with videos related to

Pageof 24
Sort By:
Photoacoustics|December 25, 2023
Multispectral optoacoustic tomography enables assessment of disease activity in paediatric inflammatory bowel diseaseAdrian P Regensburger, Markus Eckstein, Matthias Wetzl, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Medcomm|January 16, 2026
Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaJian-Guo Zhou, Markus Eckstein, Haitao Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 8, 2023
Contrast-Enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal TractLars-Philip Paulus, Adrian Buehler, Alexandra L Wagner, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
Cell Reports|December 14, 2022
The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress responseHarald Schuhwerk, Julia Kleemann, Pooja Gupta, et al.
Pageof 24

Showing results (191-200 of 238) with videos related to

Sort By:
Pageof 24
Photoacoustics|December 25, 2023
Multispectral optoacoustic tomography enables assessment of disease activity in paediatric inflammatory bowel diseaseAdrian P Regensburger, Markus Eckstein, Matthias Wetzl, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Medcomm|January 16, 2026
Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaJian-Guo Zhou, Markus Eckstein, Haitao Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 8, 2023
Contrast-Enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal TractLars-Philip Paulus, Adrian Buehler, Alexandra L Wagner, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
Cell Reports|December 14, 2022
The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress responseHarald Schuhwerk, Julia Kleemann, Pooja Gupta, et al.
Pageof 24